Globe Life Inc. (GL)
| Market Cap | 12.16B +14.1% |
| Revenue (ttm) | 6.27B +5.6% |
| Net Income | 1.19B +3.1% |
| EPS | 14.92 +8.4% |
| Shares Out | 76.85M |
| PE Ratio | 10.60 |
| Forward PE | 9.94 |
| Dividend | $1.32 (0.83%) |
| Ex-Dividend Date | Oct 5, 2026 |
| Volume | 511,481 |
| Open | 159.60 |
| Previous Close | 159.79 |
| Day's Range | 157.38 - 159.96 |
| 52-Week Range | 127.85 - 191.55 |
| Beta | 0.46 |
| Analysts | Buy |
| Price Target | 185.18 (+17.05%) |
| Earnings Date | Oct 21, 2026 |
About GL
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; ... [Read more]
Financial Performance
In 2025, Globe Life's revenue was $5.99 billion, an increase of 3.74% compared to the previous year's $5.78 billion. Earnings were $1.16 billion, an increase of 8.45%.
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for GL stock is "Buy." The 12-month stock price target is $185.18, which is an increase of 17.05% from the latest price.
News
Did Globe Life Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
Globe Life Inc. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Globe Life Inc. (GL)
Globe Life disclosed roughly $7 million in excess prior-period Medicare Supplement claims linked to a federal CMS processing delay, and GL shares fell over 8%. The investigation concerns what investor...
Globe Life price target lowered to $182 from $190 at Keefe Bruyette
Keefe Bruyette lowered the firm’s price target on Globe Life (GL) to $182 from $190 and keeps an Outperform rating on the shares.
Globe Life price target lowered to $180 from $191 at Wells Fargo
Wells Fargo lowered the firm’s price target on Globe Life (GL) to $180 from $191 and keeps an Overweight rating on the shares. The firm says Q3 was a bit…
Globe Life price target lowered to $215 from $225 at TD Cowen
TD Cowen lowered the firm’s price target on Globe Life (GL) to $215 from $225 and keeps a Buy rating on the shares. The firm updated its model following quarterly…
Globe Life downgraded to Neutral from Overweight at Piper Sandler
Piper Sandler downgraded Globe Life (GL) to Neutral from Overweight with a price target of $165, down from $200. Globe Life is viewed as a “predictable safe haven” within the…
Globe Life Earnings Call Transcript: Q3 2026
Q3 net operating income rose 1% and premiums grew 7%, while CMS-related claims and Evry losses pressured health margins. FY2026 normalized EPS growth is projected at ~8%; FY2027 EPS guidance implies 7% growth at midpoint, supported substantially by buybacks.
Globe Life Earnings release: Q3 2026
Globe Life released its Q3 2026 earnings on October 22, 2026, summarizing the period's financial results.
Globe Life reports Q3 EPS $4.84, consensus $4.89
Reports Q1 revenue $1.6B, consensus $1.61B.
GLOBE LIFE INC. REPORTS THIRD QUARTER 2026 RESULTS
MCKINNEY, Texas, Oct. 21, 2026 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended September 30, 2026, net income was $4.62 per diluted common share, compared with $4....
Globe Life price target raised to $195 from $193 at JPMorgan
JPMorgan raised the firm’s price target on Globe Life (GL) to $195 from $193 and keeps an Overweight rating on the shares. The firm adjusted targets in the life insurance…
Globe Life Inc. Announces Third Quarter 2026 Earnings Release and Conference Call
MCKINNEY, Texas, Oct. 7, 2026 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) will announce its Third Quarter 2026 financial results after the market closes on Wednesday, October 21, 2026. At that time, a ...
Globe Life price target lowered to $197 from $208 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Globe Life (GL) to $197 from $208 and keeps an Overweight rating on the shares.
Globe Life announces new share repurchase authorization for up to $2.5B
Globe Life (GL) announced a new authorization, effective August 15, to repurchase up to $2.5B of common stock in the future under the company’s existing share repurchase program. This authorization…
Globe Life Announces New Share Repurchase Authorization
MCKINNEY, Texas, Aug. 10, 2026 /PRNewswire/ -- Globe Life Inc. (NYSE:GL) announced a new authorization, effective August 15, 2026, to repurchase up to $2.5 billion of common stock in the future under ...
GLOBE LIFE INC. DECLARES DIVIDEND
MCKINNEY, Texas, Aug. 6, 2026 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) announced that its Board of Directors has declared a quarterly dividend of $0.33 per share on all of the outstanding common sto...
Globe Life price target lowered to $190 from $192 at Keefe Bruyette
Keefe Bruyette lowered the firm’s price target on Globe Life (GL) to $190 from $192 and keeps an Outperform rating on the shares.
Globe Life Earnings Call Transcript: Q2 2026
Q2 saw strong earnings growth with net income up 20% and net operating income up 10% year-over-year. Premium revenue and investment income rose, while share repurchases and dividends returned significant capital to shareholders. Guidance for 2026 EPS was raised, supported by robust underwriting margins and continued operational momentum.
Globe Life Earnings release: Q2 2026
Globe Life released its Q2 2026 earnings on July 23, 2026, summarizing the period's financial results.
Globe Life Quarterly report: Q2 2026
Globe Life has published its Q2 2026 quarterly earnings report on July 23, 2026.
Globe Life reports Q2 NII $3.61, consensus $3.68
Reports Q2 revenue $1.60B, consensus $1.59B.
Globe Life raises FY26 EPS view to $15.55-$15.95 from $14.95-$15.65
FY26 EPS consensus $15.65.
GLOBE LIFE INC. REPORTS SECOND QUARTER 2026 RESULTS
MCKINNEY, Texas, July 22, 2026 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended June 30, 2026, net income was $3.65 per diluted common share, compared with $3.05 pe...
Globe Life price target raised to $225 from $215 at TD Cowen
TD Cowen raised the firm’s price target on Globe Life (GL) to $225 from $215 and keeps a Buy rating on the shares. The firm upped targets in the life…
Globe Life price target raised to $201 from $181 at JPMorgan
JPMorgan analyst Pablo Singzon raised the firm’s price target on Globe Life (GL) to $201 from $181 and keeps an Overweight rating on the shares. The firm adjusted targets in…